Shortages in supply reported by marketing authorisation holders published as open data
Starting 1 December 2020, Fimea will publish medicinal product supply shortages reported by marketing authorisation holders as open data. Supply shortages that are currently ongoing and those that have ended within the past 30 days will in future be published daily .In addition to open data the information on currently ongoing supply shortages will be published in the Fimea supply shortage search. Users can also subscribe to an RSS Feed of the search data.
The file containing supply shortage data reported by marketing authorisation holders will include each medicinal product’s unique identifier and the estimated start and end dates for the supply shortage. Marketing authorisation holders may update estimated dates numerous times as a supply shortage progresses.
Fimea will transfer the information reported by a marketing authorisation holder to the open data file unchanged. Fimea is not responsible for ensuring the data is correct and, for this reason, cannot independently correct any mistakes contained in the data. Where necessary, the marketing authorisation holder will be asked to update their erroneous notification.
In the future, supply shortage notifications can be received in Fimea e-services
Fimea’s objective is to receive supply shortage notifications from marketing authorisation holders via their electronic service. This is expected to simplify the management of notifications and, therefore, to reduce the number of mistakes in notifications.